[ad_1]
Pacira BioSciences PCRX reported its Q2 earnings results on Wednesday, August 3, 2022.
Here’s what investors need to know about the announcement.
Earnings
Pacira BioSciences missed estimated earnings by 42.05%, reporting an EPS of $0.51 versus an estimate of $0.88.
Revenue was up $33.82 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.19 which was followed by a 6.75% drop in the share price the next day.
Here’s a look at Pacira BioSciences’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.83 | 0.90 | 0.65 | 0.69 |
| EPS Actual | 0.64 | 0.97 | 0.72 | 0.77 |
| Revenue Estimate | 159.49M | 155.74M | 130.38M | 128.01M |
| Revenue Actual | 157.99M | 159.19M | 127.72M | 135.59M |
To track all earnings releases for Pacira BioSciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.